GlassScriptPhysician profile
Zaka U Khan
NPI 1205872405
$9,034.40
in general payments reported to CMS, 2019-2025
16 companies · $1,851 in 2025
The $1,851 reported for 2025 was more than what 75% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $88.41 · 2020: $53.00 · 2022: $2,630 · 2023: $3,586 · 2024: $825 · 2025: $1,851.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,500 · Travel and Lodging: $1,852 · Food and Beverage: $911.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,500.00 |
| Travel and Lodging | $1,852.18 |
| Food and Beverage | $910.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,689.00 | 2023-2024 | Da Vinci Surgical System |
| Ethicon INC. | $1,471.82 | 2022 | |
| Pinnacle Biologics, INC | $1,013.91 | 2022 | |
| Abbott Laboratories | $757.32 | 2022-2025 | Na, Amplatzer Amulet, Aveir |
| Pulmonx Corporation | $647.98 | 2023-2025 | Zephyr Endobronchial Valve, Chartis Catheter, Pulmonx Chartis Tablet Console |
| Cook Medical LLC | $531.16 | 2025 | Blue Rhino |
| Coaptech, INC. | $475.50 | 2025 | Puma System |
| Inspire Medical Systems, INC. | $137.74 | 2022-2024 | Inspire |
| Olympus America INC. | $127.48 | 2024-2025 | Spiration Valve System |
| Insmed, INC. | $53.37 | 2019-2023 | Arikayce |
| Genentech USA, INC. | $38.00 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $22.32 | 2020 | |
| Gilead Sciences, INC. | $19.95 | 2023 | Veklury |
| Novartis Pharmaceuticals Corporation | $18.17 | 2019 | |
| Merck Sharp & Dohme LLC | $16.55 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grifols USA, LLC | $14.13 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zaka Khan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.